Guardant Health is up a bit on the day, funds flowing in kept the price up 1.61% since yesterday.
Guardant Health doesn't seem to be at a very clear reversal point in either direction. Guardant Health hasn't been looking too hot recently, some shareholders have been dumping shares over the last few months which has been driving prices down. In the past 3 months, the asset has lost -15.68 of it's value. So it's not looking great, I'd probably wait for a clearer support level before coming in. GH might find some support at the 38.29 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts are pretty neutral on Guardant Health right now, so not much useful information here. The current Analysts Sentiment Score is -7.72. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. On 2024-04-15 The Goldman Sachs Group lowered their price target by -12.5% to $28.00. Guggenheim reiterated a rating of Neutral on 2024-04-05. Piper Sandler announced a lowering of their price target to $30.00 from $40.00 on 2024-02-26. JPMorgan Chase & Co. provided a price target decease of -25% to $45.00 from $60.00 on 2024-02-23. On 2024-02-23 Canaccord Genuity Group lowered their price target by -10% to $45.00. On 2023-12-13 Wolfe Research started covering Guardant Health with a rating of Peer Perform. Raymond James upgraded from Market Perform to Outperform on 2023-11-13 and added a price target of $27.00. Morgan Stanley announced a lowering of their price target to $50.00 from $55.00 on 2023-11-08. Citigroup reiterated a rating of Buy on 2023-10-02 and provided a price target of $50.00. Sanford C. Bernstein initiated a rating of Outperform on 2023-09-28 and they set their price target at $34.00.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| GH | -7.72 | 41.23 | 0 | 22.28 | -78.94 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| GH | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| GH | 5.71 | %6.26221 | 4.6 | 7.722 | 7370000 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| GH |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies | 1.21 | 2.73 | 9.45 | 6.36 | -17.98 | -38.07 | -53.19 | 24 | -67.78 | -68.18 | -89.95 | -60811.01 | 0.00 | 0 | 150 | 7.83993 |
| MTLS | Materialise NV | 1.13 | 2.28 | 0.75 | 2.08 | -2.53 | -5.44 | -38.82 | 25 | -48.67 | -29.27 | -36.93 | -48233.17 | 169.28 | 0 | 0 | 0.983039 |
| TDOC | Teladoc Health, Inc. | 1.12 | -1.62 | -4.56 | -12.59 | -37.29 | -24.51 | -49.39 | 43 | -24.98 | -33.71 | -40.36 | -27887.95 | -843.48 | 0 | 0 | 8.78425 |
| VCYT | Veracyte, Inc. | 1.09 | 0.79 | 0.05 | -1.64 | -18.60 | -8.95 | -8.58 | 16 | -6.77 | -4.31 | -2.36 | -13628.83 | -197.98 | 0 | 125 | 4.97884 |
| TXG | 10x Genomics, Inc. Class | 1.09 | 4.53 | -3.24 | -24.71 | -43.31 | -24.77 | -49.76 | 8 | -13.60 | -12.66 | -11.64 | -20764.54 | -2252.51 | 0 | 125 | 8.00406 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
